Latest Executive Incentives News

Lithium Universe Limited appoints Iggy Tan as full-time CEO and Executive Chairman, signalling a strategic push to fast-track lithium refinery projects and innovative recycling technologies.

EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.

Castle Minerals has significantly expanded its Western Australian gold footprint by acquiring Meekasan Pty Ltd, boosting its contiguous landholding in the Meekatharra district to 184km². The move is complemented by key board changes aimed at accelerating growth.

TPG Telecom reported a robust FY25 with strategic asset sales, a major network sharing deal, and a $3 billion capital return, underpinning strong financial and sustainability progress.

ARN Media Limited reported a 10% revenue decline in FY25 alongside a strategic reset focusing on digital transformation and cost savings. Leadership changes and improved cash flow underpin the company’s pivot to a digitally driven entertainment model.

Eminence Minerals Limited has issued 2.7 million unquoted CEO performance rights as part of a new executive appointment, utilising its 15% placement capacity without shareholder approval.

Mercury NZ Limited reported a 130% surge in net profit for HY2026, driven by strong renewable generation and disciplined cost management, while advancing major geothermal and wind projects on schedule.

Electro Optic Systems reported a 27% revenue drop to $128.5 million in FY2025 but posted a net profit of $18.6 million, boosted by the sale of EM Solutions. The company strengthened its position with key contract wins and acquisitions, including the UK-based Interceptor business and a conditional deal for MARSS.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

Great Dirt Resources has raised $1.446 million through a discounted share placement and appointed seasoned resource executives to drive its growth strategy.

Adheris Health has expanded its operating cost reduction program, aiming for more than 30% savings by FY27, while refocusing on high-growth pharmaceutical categories and enhancing its AI-powered patient engagement platform.